Update: Hypogonadotropic Hypogonadism in Type 2 Diabetes and Obesity
Open accessThe DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Studies over the last few years have clearly established that at least 25% of men with type 2 diabetes have subnormal free testosterone concentrations in association with inappropriately low LH and FSH concentrations. Another 4% have subnormal testosterone concentrations with elevated LH and FSH concentrations. The Endocrine Society, therefore, now recommends the measurement of testosterone in patients with type 2 diabetes on a routine basis. The subnormal testosterone concentrations are not related to glycosylated hemoglobin or duration of diabetes, but are associated with obesity, very high C-reactive protein concentrations, and mild anemia. In addition, subnormal testosterone concentrations in these men are associated with a two to three times elevated risk of cardiovascular events and death in two early studies. Short-term studies of testosterone therapy in hypogonadal men with type 2 diabetes have demonstrated an increase in insulin sensitivity and a decrease in waist circumference. However, the data on the effect of testosterone replacement on glycemic control and cardiovascular risk factors such as cholesterol and C-reactive protein concentrations are inconsistent. As far as sexual function is concerned, testosterone treatment increases libido but does not improve erectile dysfunction and thus, phosphodiesterase inhibitors may be required. Trials of a longer duration are clearly required to definitively establish the benefits and risks of testosterone replacement in patients with type 2 diabetes and low testosterone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Obese subjects often have reduced gonadotropin concentrations indicating that the primary effect is mediated at the hypothalamus-pituitary level rather than at the testicular level [38].”
From Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis (2017) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The increased amount of estrogen levels might, in turn, play a negative feedback on both the hypothalamus and the pituitary, leading to decreased LH secretion (22,55).”
From Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis (2013) · cites this paper as [55]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Thus high BMI seems to repress serum T mainly via central inhibitory effects on gonadotropin secretion [38, 41].”
From Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis (2017) · cites this paper as [38]
The cited source says what the claim attributes to it.
In the citing paper
“Based on these and other studies (53,54), obesity-related male hypogonadism is now considered as a form of hypogonadotropic hypogonadism (see for a review, references (55,56)).”
From Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis (2013) · cites this paper as [55]
The cited source says what the claim attributes to it.
In the citing paper
“Accordingly, patients with T2DM and insulin resistance show a higher prevalence of hypogonadotropic hypogonadism (54,55,60)”
From Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis (2013) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170
Self-citationAdverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
Khosla, S., Amin, S., & Orwoll, E. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0002 · Cited by 930
Laaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T.-P., Valkonen, V.-P., Salonen, R., & Salonen, J. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1036 · Cited by 920
Low Serum Testosterone and Mortality in Older Men
Laughlin, G. A., Barrett-Connor, E., & Bergstrom, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1792 · Cited by 798
Kapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02166 · Cited by 791
Khaw, K.-T., Dowsett, M., Folkerd, E., Bingham, S., Wareham, N., Luben, R., Welch, A., & Day, N. (2007) · Circulation · doi:10.1161/circulationaha.107.719005 · Cited by 743
Sex hormone-binding globulin and risk of type 2 diabetes in women and men
Ding, E. L., Song, Y., Manson, J. E., Hunter, D. J., Lee, C. C., Rifai, N., Buring, J. E., Gaziano, J. M., & Liu, S. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804381 · Cited by 726
Cited by
Items 101–200 of 313
Vignera, S. L., Cannarella, R., Garofalo, V., Crafa, A., Barbagallo, F., Condorelli, R. A., & Calogero, A. E. (2025) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-025-01425-9 · Cited by 39
Giltay, E. J., Geleijnse, J. M., Heijboer, A. C., de Goede, J., Griep, L. M. O., Blankenstein, M. A., & Kromhout, D. (2012) · International Journal of Andrology · doi:10.1111/j.1365-2605.2012.01255.x · Cited by 25
“…male reproduction function (e.g. erectile function and sperm quality) or other androgen-related physiology such as body composition (e.g. bone mineral density, muscle development, fat distribution), prostate gland physiology, and erythropoiesis (Kaufman & Vermeulen, 2005; Dandona & Dhindsa, 2011).”
BackgroundThe Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer
Gunter, J. H., Lubik, A. A., McKenzie, I., Pollak, M., & Nelson, C. C. (2012) · Advances in Urology · doi:10.1155/2012/248607 · Cited by 28
“[57] P.”
BackgroundNew Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men
Karakas, S. E., & Surampudi, P. N. (2018) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.06.001 · Cited by 25
Molina‐Vega, M., Asenjo‐Plaza, M., García‐Ruiz, M. C., Varea‐Marineto, E., Casal‐Nievas, N., Álvarez‐Millán, J. J., Cabezas-Sánchez, P., Cardona, F., Queipo‐Ortuño, M. I., Castellano‐Castillo, D., et al. (2019) · Obesity · doi:10.1002/oby.22579 · Cited by 23
“IIEF-5 questionnaire, median (IQR), points 22 (20-24) 22 (18-24) 0.”
ResultThe Incidence of Hypogonadotropic Hypogonadism in Type 2 Diabetic Men in Polish Population
Rabijewski, M., Papierska, L., Zgliczyński, W., & Piątkiewicz, P. (2013) · BioMed Research International · doi:10.1155/2013/767496 · Cited by 24
“Thus, in view of the inverse relationship between BMI and testosterone concentrations in both type 1 and type 2 diabetes, HH is probably related to insulin resistance [4, 5].”
BackgroundInfluentialPham, N. H., Bena, J., Bhatt, D. L., Kennedy, L., Schauer, P. R., & Kashyap, S. R. (2018) · Obesity Surgery · doi:10.1007/s11695-017-2881-5 · Cited by 21
“Male hypogonadism has been documented both in obesity and in 30–40% of individuals with type 2 diabetes (T2DM) [1].”
BackgroundInfluentialA National Multicenter Study of Leptin and Leptin Receptor Deficiency and Systematic Review
Besci, Ö., Fırat, S. N., Özen, S., Çetinkaya, S. Ç., Akın, L., Kör, Y., Pekkolay, Z., Özalkak, Ş., Özsu, E., Erdeve, Ş. S., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad099 · Cited by 23
Testosterone concentration and insulin sensitivity in young men with type 1 and type 2 diabetes
Kelsey, M. M., Bjornstad, P., McFann, K., & Nadeau, K. J. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12255 · Cited by 20
“In recent times, considerable attention has been given to the association of gonadal dysfunction with reduced IS, T2D, and obesity (20).”
BackgroundA link between hypothyroidism, obesity and male reproduction
Aiceles, V., & Ramos, C. D. F. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0054 · Cited by 23
“The impacts of obesity on male reproduction have been demonstrated in the last years [97].”
BackgroundAssessment of Female Sexual Function in Pregnant Women with Gestational Diabetes Mellitus
Souza, F. D. O., Dias, L. A. R., Franco, M. D. M., Guirro, E. C. D. O., Cavalli, R. D. C., Lara, L. A. D. S., & Ferreira, C. H. J. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12106 · Cited by 21
Male gonadal axis function in patients with type 2 diabetes
Costanzo, P., & Knoblovits, P. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0014 · Cited by 22
Osteoporosis in men: recent progress
Adler, R. A. (2013) · Endocrine · doi:10.1007/s12020-013-9880-7 · Cited by 22
“An important example of this is the secondary hypogonadism found commonly in obese, diabetic men [23].”
BackgroundGlintborg, D., Christensen, L. L., Kvorning, T., Larsen, R., Brixen, K., HOUGAARD, D. M., Richelsen, B., Bruun, J. M., & Andersen, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/539156 · Cited by 23
“Testosterone replacement therapy is indicated in severe hypogonadism, whereas the indication for testosterone therapy (TT) in aging hypogonadal men without hypothalamic, pituitary, or testicular disease is debated [1, 2].”
BackgroundChen, D., Cao, S., Chang, B., Ma, T., Gao, H., Tong, Y., Li, T., Han, J., & Yi, X. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.10.005 · Cited by 22
The Prevalence and Predictors of Androgen Deficiency in Taiwanese Men With Type 2 Diabetes
Liu, R., Chung, M., Wang, P., Chen, C., Lee, J., Lee, W., Chancellor, M. B., Yang, K. D., & Chuang, Y. (2013) · Urology · doi:10.1016/j.urology.2013.03.023 · Cited by 21
Testosterone therapy in older men with late-onset hypogonadism: a counter-rationale
Basaria, S. (2013) · Endocrine Practice · doi:10.4158/ep13318.ra · Cited by 18
Wu, Y., & Sung, W. (2024) · Pharmaceuticals · doi:10.3390/ph17091233 · Cited by 21
“Research has shown that at least 25% of men diagnosed with T2DM exhibit testosterone deficiency [53].”
BackgroundAssessment of Hypogonadism in Men With Type 2 Diabetes: A Cross-Sectional Study From Saudi Arabia
Hayek, A. A., Robert, A. A., Alshammari, G., Hakami, H., & Dawish, M. A. A. (2017) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551417710209 · Cited by 21
Matsumoto, A. M., & Bremner, W. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00019-8 · Cited by 27
Liu, F., Tu, Y., Zhang, P., Bao, Y., Han, J., & Jia, W. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.11.009 · Cited by 22
Oestradiol concentrations are not elevated in obesity‐associated hypogonadotrophic hypogonadism
Dhindsa, S., Batra, M., Kuhadiya, N. D., & Dandona, P. (2013) · Clinical Endocrinology · doi:10.1111/cen.12236 · Cited by 18
Self-citationLifestyle, metabolic disorders and male hypogonadism – A one-way ticket?
Crisóstomo, L., Pereira, S., Monteiro, M. P., Raposo, J. F., Oliveira, P. F., & Alves, M. G. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110945 · Cited by 19
Fariello, R. M., de Carvalho, R. C., Spaine, D. M., Andretta, R. R., Junior, E. M. C., Sá, G., Cedenho, A. P., & Fraietta, R. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05350-9 · Cited by 22
Degechisa, S. T., Kinde, S., Dedefo, G., Mudi, K., & Tarekegn, G. (2018) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2018.1541668 · Cited by 19
“More importantly, obesity appears to play an important synergistic role in this pathogenesis.(4,6)”
BackgroundInfluentialSepu, N., Adeleye, J. O., & Kuti, M. A. (2021) · Journal of the National Medical Association · doi:10.1016/j.jnma.2020.11.014 · Cited by 16
The prevalence of Hypogonadism among diabetic and non-diabetic men in Jordan
Hayek, A. A., Khawaja, N. M., Khader, Y. S., Jafal, S., & Ajlouni, K. M. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.11.004 · Cited by 18
“Hypogonadotropic hypogonadism was present in 25%–40% of patients with type 2 diabetes (Dandona & Dhindsa, 2011).”
BackgroundKisspeptin and Glucose Homeostasis
Izzi‐Engbeaya, C. N., Hill, T. G., & Bowe, J. E. (2019) · Seminars in Reproductive Medicine · doi:10.1055/s-0039-3400242 · Cited by 15
Saidi, A. O., Akintayo, C. O., Atuma, C. L., Mahmud, H., Sabinari, I. W., Oniyide, A. A., Aturamu, A., Agunbiade, T. B., & Olaniyi, K. S. (2022) · Theriogenology · doi:10.1016/j.theriogenology.2022.02.029 · Cited by 14
Apigenin improves testosterone synthesis by regulating endoplasmic reticulum stress
Wu, L., Qu, J., Mou, L., & Liu, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117075 · Cited by 17
In Search for a Common Pathway for Health Issues in Men - the Sign of a Holmesian Deduction
Aoun, F. Y., Chemaly, A. K., Albisinni, S., Zanaty, M., & Roumeguère, T. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2016.17.1.1 · Cited by 13
“Animal studies over the last few years have clearly established that insulin action and insulin responsiveness in the brain are necessary for the maintenance of the functional integrity of the hypothalamo-hypophyseal-gonadal axis (Dandona and Dhindsa, 2011).”
BackgroundWong, P. W., Lee, H. M., Lau, E. S. H., Lim, C. K. P., Ronald, C. W., Kong, A. P. S., Chan, J. C. N., & Luk, A. O. Y. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3081 · Cited by 13
“com the level of the hypothalamus‐pituitary.(3,4) Consistent with known physiological action of testosterone, low testosterone bioavailability results in unfavourable metabolic phenotype including reduced lean muscle mass, central adiposity, and insulin resistance.”
BackgroundSexualität bei Übergewicht und Adipositas
Abrahamian, H., & Kautzky‐Willer, A. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0430-9 · Cited by 18
Pelletier, R. ‐., Layeghkhavidaki, H., & Vitale, M. L. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00583-2 · Cited by 15
“Around 25% of type 2 diabetes men exhibit hypogonadotropic hypogonadism [3].”
BackgroundMills, E., & Dhillo, W. S. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13201 · Cited by 13
“HH occurs in 25%–40% of men with type 2 diabetes mellites.(71)”
BackgroundTan, C., Mori, M., Adachi, Y., Wakai, K., Suzuki, S., Suzuki, K. A. O., Hashimoto, S., Watanabe, Y., & Tamakoshi, A. (2016) · PubMed Central · doi:10.22034/apjcp.2016.17.10.4681 · Cited by 12
“On the contrary, in diabetic men, decreased SHBG can also increase the bioavailable testosterone to some degree; but in fact, testosterone concentration of diabetic men is lower than no-diabetic men, because gonadotropic stimulation significantly decreases in diabetic men, thus the testosterone production in the testi…”
BackgroundThe Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe?
Kounatidis, D. C., Vallianou, N. G., Rebelos, E., Vallianou, K., Diakoumopoulou, E., Makrilakis, K., & Tentolouris, N. (2025) · Biomolecules · doi:10.3390/biom15091284 · Cited by 16
Shaikh, S. R., Shaver, P. R., & Shewchuk, B. M. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800219 · Cited by 11
Testosterone and Glucose Homeostasis in Adult Males: Current Insights and Future Prospects
Milionis, C., Koukkou, E. G., Venaki, E., & Ilias, Ι. (2024) · Discovery Medicine · doi:10.24976/discov.med.202436184.81 · Cited by 12
Abler, L. L., O’Driscoll, C. A., Colopy, S. A., Keil, K. P., Wang, P., Wang, Z., Hartmann, F. A., Crader, S. M., Oellete, J. N., Mehta, V., et al. (2021) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00112.2021 · Cited by 10
Avendaño, M. S., Perdices-López, C., Guerrero‐Ruiz, Y., Ruíz-Pino, F., Rodriguez-Sanchez, A. B., Sanchez-Tapia, M. J., Sobrino, V., Pineda, R., Barroso, A., Correa-Sáez, A., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155932 · Cited by 13
Primary and Secondary Hypogonadism in Male Persons with Diabetes Mellitus
Martins, J. M., Jorge, M. D. P., Maia, C. M., Roque, J., Lemos, C., Nunes, D., Reis, D., & Mota, C. (2021) · International Journal of Endocrinology · doi:10.1155/2021/8799537 · Cited by 12
“More probably, inflammatory mediators can contribute to the central suppression of the hypothalamic-pituitary-gonadic axis and these may be increased in obese diabetic subjects but also in old, longstanding, and complicated diabetic subjects without obesity [33].”
BackgroundResultPospíšilová, H., Vaňková, M., Hill, M., Meloun, M., Bendlová, B., Dušková, M., & Stárka, L. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.02.005 · Cited by 11
“There is consistent evidence from randomized trials that testosterone therapy alters body composition in a metabolic favourable manner, but changes are modest and have not consistently translated in insulin resistance and improvements in glucose metabolism [24,36,37].”
BackgroundTestosterone Replacement in Men with Treated and Untreated Prostate Cancer
Khera, M. (2013) · Sexual Medicine Reviews · doi:10.1002/smrj.16 · Cited by 10
Sex/gender differences in metabolic syndrome among cancer survivors in the US: an NHANES analysis
Ezeani, A., Echouffo-Tcheugui, J. B., & Agurs‐Collins, T. (2023) · Journal of Cancer Survivorship · doi:10.1007/s11764-023-01404-2 · Cited by 9
“Although levels and visceral fat mass [30].”
Body composition and testosterone in men: a Mendelian randomization study
Ikehata, Y., Hachiya, T., Kobayashi, T., Ide, H., & Horie, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1277393 · Cited by 13
Allameh, F., Pourmand, G., Bozorgi, A., Nekuie, S., & Namdari, F. (2016) · PubMed Central · Cited by 12
Management of congenital hypogonadotropic hypogonadism in females
Naseem, H. S., Lokman, M., & Fitzgerald, C. T. (2021) · Human Fertility · doi:10.1080/14647273.2021.1998929 · Cited by 11
“The state of energy deficit or stress can be triggered by eating disorders, excessive exercise, physiological stress, chronic illness, and drugs (Chan & Mantzoros, 2005; Dandona & Dhindsa, 2011; Dhindsa et al., 2004; Mu ~ noz & Argente, 2002).”
BackgroundMaiorino, M. I., Bellastella, G., & Esposito, K. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_16 · Cited by 9
Rotter, I., Kosik-Bogacka, D. I., Dołęgowska, B., Skonieczna‐Żydecka, K., Pawlukowska, W., & Laszczyńska, M. (2015) · The Aging Male · doi:10.3109/13685538.2015.1077507 · Cited by 11
Ferrandis-Cortés, C., Martínez-Jabaloyas, J. M., Calzadilla, N. D., Hernández-Medina, J. A., & Chuan-Nuez, P. (2013) · Urologia Internationalis · doi:10.1159/000348791 · Cited by 10
Bonnet, F., Vaduva, P., Halimi, J., Dosda, A., Ducluzeau, P., Koppe, L., & Fauchier, L. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02930-2 · Cited by 9
“The prevalence of moderate testosterone deficiency is common among patients with diabetes and obesity with a prevalence estimated at about 25% [2].”
Yıldırım, O. G., Güney, C., Alçığır, M. E., & Akar, F. (2023) · Reproductive Biology · doi:10.1016/j.repbio.2023.100815 · Cited by 8
Wang, A., Arver, S., Flanagan, J. N., Gyberg, V., Näsman, P., Ritsinger, V., & Mellbin, L. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118802543 · Cited by 9
Aminuddin, A., Salamt, N., Fuad, A. F. A., Chin, K., Ugusman, A., Soelaiman, I. N., & Ngah, W. Z. W. (2019) · Medicina · doi:10.3390/medicina55090575 · Cited by 7
“In obese individuals, the increased aromatase activity from fat mass leads to suppression of hypothalamic-pituitary-testis pathway, thereby reducing the production of testosterone from the Leydig cell in the testis [10,11].”
BackgroundElrifai, A., Kotb, A. F., Sharaki, O., & Abdelhady, M. (2015) · Polish Annals of Medicine · doi:10.1016/j.poamed.2015.07.001 · Cited by 9
Glintborg, D., Christensen, L. L., Kvorning, T., Larsen, R., Højlund, K., Brixen, K., HOUGAARD, D. M., Handberg, A., & Andersen, M. (2015) · PubMed · doi:10.3109/00365513.2015.1074274 · Cited by 8
Mirzaei, M. R., Amini, M., & Aminorroaya, A. (2012) · PubMed Central · Cited by 11
Kemp, T., & Rheeder, P. (2015) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2015.1056478 · Cited by 11
Osteoporosis in patients with diabetes after kidney transplantation
Gosmanova, E. O., & Gosmanov, A. R. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9397-5 · Cited by 8
Reproductive Dysfunctions in Males with Type 2 Diabetes Mellitus: An Updated Review
Ray, S., & Pramanik, S. (2020) · EMJ Diabetes · doi:10.33590/emjdiabet/20-00171 · Cited by 10
Li, C., Zhang, Y. Z., Wang, Y., Gu, C., Li, B., Ma, M., Xu, X., Chen, Y., & Zheng, Z. J. (2024) · Nutrition and Diabetes · doi:10.1038/s41387-024-00308-z · Cited by 10
Rajpoot, A., Pandey, A. K., Roy, V. K., & Mishra, R. K. (2025) · Andrologia · doi:10.1155/and/5517176 · Cited by 11
A ripple effect? The impact of obesity on sperm quality and function
Alfaiate, M. I., Tavares, R. S., & Ramalho‐Santos, J. (2024) · Reproduction Fertility and Development · doi:10.1071/rd23215 · Cited by 9
Endocrine changes (beyond diabetes) after bariatric surgery in adult life.
Savastano, S., Somma, C. D., Pivonello, R., Tarantino, G., Orio, F., Nedi, V., & Colao, A. (2013) · PubMed · doi:10.3275/8880 · Cited by 7
Testosterone deficiency in non-obese type 2 diabetic male patients
Gouda, S. I., Aboelnaga, M. M., Elbeltagy, A. M. G., & Elbaz, A. (2022) · Archivio Italiano di Urologia e Andrologia · doi:10.4081/aiua.2022.4.464 · Cited by 7
Hypogonadism in Systemic Diseases
Rochira, V. (2017) · Endocrinology · doi:10.1007/978-3-319-29456-8_28-1 · Cited by 11
Effects of Peptide YY on the Hypothalamic-Pituitary-Gonadal Axis in Healthy Men
Izzi‐Engbeaya, C. N., Jones, S., Crustna, Y., Machenahalli, P. C., Papadopoulou, D., Modi, M., Panayi, C., Starikova, J., Eng, P. C., Phylactou, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz103 · Cited by 7
“Secondary hypogonadism occurs in up to 40% of obese men, which is associated with higher body weight and increased insulin resistance (14).”
BackgroundLong-term follow-up of gonadal dysfunction in morbidly obese adolescent boys after bariatric surgery
Chin, V. L., Willliams, K. M., Donnelley, T., Censani, M., Conroy, R., Lerner, S. E., Oberfield, S. E., McMahon, D. J., Zitsman, J. L., & Fennoy, I. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0261 · Cited by 7
Obesity and Testicular Function
Ilacqua, A., Francomano, D., & Aversa, A. (2014) · Springer eBooks · doi:10.1007/978-3-319-09045-0_10 · Cited by 9
“Male obesity is associated with increased aromatase activity within adipocytes [14], and oestradiol in turn exerts a negative feedback effect on LH secretion from the pituitary [15].”
BackgroundSex hormones, obesity and type 2 diabetes-is there a link?
Gambineri, A. (2018) · Endocrine Abstracts · doi:10.1530/endoabs.56.s18.1 · Cited by 7
The occurrence of hypogonadotropic hypogonadism in Chinese men with type 2 diabetes
Zhou, Y., Tian, R., Wang, X., Sun, J., Zhu, L., & An, X. (2022) · Clinical Endocrinology · doi:10.1111/cen.14680 · Cited by 6
“Hypogonadotropic hypogonadism (HH) is the major form of secondary hypogonadism and previous documents suggested that HH occurs commonly in young and middle‐aged male type 2 diabetes.(17,19,26) Nearly one‐third of American men with type 2 diabetes have low testosterone concentrations along with inappropriately low LH a…”
BackgroundResultRemission of type 2 diabetes in a hypogonadal man under long-term testosterone therapy
Haider, A., Haider, K. S., & Saad, F. (2017) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-17-0084 · Cited by 7
Hohl, A., & Ronsoni, M. F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8684-8_15 · Cited by 6
Yu, Y., Wang, Y., Xu, L., Li, W., & Wang, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1319582 · Cited by 6
Screening and managing erectile dysfunction in diabetic patients (review)
Colson, M.-H., & Roussey, G. (2012) · Sexologies · doi:10.1016/j.sexol.2012.02.002 · Cited by 9
Effects of testosterone replacement on glucose and lipid metabolism
Errazuriz, I., Dube, S., Basu, A., & Basu, R. (2015) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000061 · Cited by 7
Kumar, R., Malhotra, N., & Jacob, J. J. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.01.009 · Cited by 6
Li, Y.-R., Tsao, S., Chen, C., Hou, C., Tsui, K.-H., Juang, H., & Lin, Y. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226808 · Cited by 6
“Male obesity and type 2 diabetes mellitus are associated with increased aromatase activity in adipocytes, resulting in increased serum oestradiol levels [14].”
BackgroundRaghuraman, R., Bhuyan, A. K., Baro, A., & Saikia, U. K. (2024) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_60_24 · Cited by 6
Dhindsa, S., Irwig, M. S., & Wyne, K. L. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0131 · Cited by 7
Self-citationTestosterone replacement therapy for physician assistants and nurse practitioners
Ramos, L., Patel, A. S., & Ramasamy, R. (2018) · Translational Andrology and Urology · doi:10.21037/tau.2017.12.09 · Cited by 7
“This association has been acknowledged by the Endocrine Society who have recommended routine testosterone measurement in all patients with type 2 diabetes mellitus (14).”
BackgroundIntranasal Insulin Administration Does Not Affect LH Concentrations in Men with Diabetes
Dhindsa, S., Chemitiganti, R., Ghanim, H., Santiago, E., Haider, A., Natalia, C., Mok, M., McKee, A. M., & Dandona, P. (2018) · International Journal of Endocrinology · doi:10.1155/2018/6170154 · Cited by 5
Self-citationPelletier, R. ‐., Layeghkhavidaki, H., Kumar, N. M., & Vitale, M. L. (2020) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00044.2020 · Cited by 6
Hypogonadism in Systemic Diseases
Rochira, V. (2017) · Endocrinology · doi:10.1007/978-3-319-44441-3_28 · Cited by 6
Obesity-Associated Comorbidities: Health Consequences
Adebibe, M., & Coppack, S. W. (2022) · Springer eBooks · doi:10.1007/978-3-030-54064-7_4-1 · Cited by 6
Effect of GH Deficiency Caused by Nonfunctioning Pituitary Masses on Serum C-reactive Protein Levels
Seki, Y., Morimoto, S., Bokuda, K., Watanabe, D., Yamashita, K., Takano, N., Amano, K., Kawamata, T., & Ichihara, A. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad137 · Cited by 5
“Although adrenal [24], thyroid [25], and gonadal [26, 27] in-sufficiencies have been reportedly associated with increased inflammation, the results of this study suggest that GH secretion, as indicated by the peak GH response to GHRP-2, is an independent factor affecting serum hs-CRP levels,…”
ResultTesticular Dysfunction in Systemic Diseases
Sartorius, G. A., & Handelsman, D. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-31574-9_34 · Cited by 7
Patients with testosterone deficiency syndrome and type 2 diabetes.
Corona, G., & Maggi, M. (2013) · PubMed · Cited by 6
Shende, P., Vadivel, S., Sanghani, D., & Khamkar, K. (2024) · Cureus · doi:10.7759/cureus.70439 · Cited by 7
Diabetes and Hypogonadism in Males
Lakshmi, G., & Mahadevan, S. (2025) · Apollo Medicine · doi:10.1177/09760016251332088 · Cited by 5
“[4] Testosterone levels correlate inversely with body mass index (BMI) and insulin resistance but usually have no correlation with the degree or duration of hyperglycaemia.”
Qu, S., Zhang, M., Su, B., Qian, C., Bu, L., Cheng, X., & Li, W. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.137885 · Cited by 4
Effect of obesity on diurnal patterns of testosterone and dehydroepiandrosterone in male subjects
Guimard, A., Vibarel-Rebot, N., Prieur, F., Baillot, A., Mongeois, E., Barrande, M. G., Lasne, F., & Collomp, K. (2013) · Science & Sports · doi:10.1016/j.scispo.2013.06.001 · Cited by 4
Herdt, C. D., Block, C. E. M. D., Francque, S., Verrijken, A., Dessel, K. V., Gaal, L. V., Cauwenberghe, J. V., & Dirinck, E. L. (2023) · Endocrine · doi:10.1007/s12020-022-03245-y · Cited by 5
“Testosterone deficiency has been associated with an increased accumulation of VAT and insulin resistance as observed in up to 25% and 40% of men having type 2 diabetes and obesity, respectively [10, 11].”
BackgroundAcosta‐Martínez, M. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_666 · Cited by 6
Adult Male Hypogonadism: A Laboratory Medicine Perspective on Its Diagnosis and Management
Livingston, M. A., & Heald, A. H. (2023) · Diagnostics · doi:10.3390/diagnostics13243650 · Cited by 9
“It has a prevalence estimated at 6–12% in the general population that increases with age [3], but it may be found in up to 40% of men with type 2 diabetes mellitus (T2D) (with overt and borderline hypogonadism at 17% and 25%, respectively) [4–8].”
BackgroundPhysiopathology, Diagnosis, and Treatment of Secondary Female Hypogonadism
Antoniou-Tsigkos, A., Μacut, D., & Mastorakos, G. P. (2018) · Endocrinology · doi:10.1007/978-3-319-44444-4_9 · Cited by 7
Personalized Medical Nutrition Therapy and Physical Exercise: The Future of Diabesity Care
Verde, L., Annunziata, G., Camajani, E., Tarsitano, M. G., Savastano, S., Colao, A., Muscogiuri, G., Caprio, M., & Barrea, L. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00688-6 · Cited by 5
Obesity, Circulating Androgens and their Precursors
(2013) · Journal of Steroids & Hormonal Science · doi:10.4172/2157-7536.1000119 · Cited by 3
Tehrani, F. R., Ghasemi, V., & Naz, M. S. G. (2025) · Basic and Clinical Andrology · doi:10.1186/s12610-025-00257-2 · Cited by 5
“…a higher prevalence of hypogonadism and altered gonadotropin levels in men with T2DM; approximately one-quarter of men diagnosed with T2DM exhibit aberrant levels of gonadotropins and testosterone, suggesting a potential interplay between hormonal imbalances and diabetes pathophysiology [51, 52].”
Metadata
- Authors
- Dandona, P., & Dhindsa, S.
- Affiliations
- Kaleida Health (US)
- Corresponding author
- Dandona, Paresh
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-09-01
- Volume
- 96
- Issue
- 9
- Pages
- 2643-2651
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3167667
- OpenAlex
- W2111728603
- Semantic Scholar
- fecffda5a7c16c9bb49b9b21398e4d0afefbc568
- Cited by
- 313
- References
- 75
- Citations by year
- 2026: 15 · 2025: 15 · 2024: 16 · 2023: 22 · 2022: 18 · 2021: 24 · 2020: 14 · 2019: 19 · 2018: 29 · 2017: 19 · 2016: 16 · 2015: 27 · 2014: 24 · 2013: 36 · 2012: 17
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk069805-04)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK069805, R01DK075877)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- hypogonadotropic hypogonadism, type 2 diabetes, obesity, androgen deficiency, free testosterone, luteinizing hormone, follicle-stimulating hormone, testosterone replacement therapy, insulin sensitivity, cardiovascular risk, C-reactive protein, anemia, sexual function, erectile dysfunction, phosphodiesterase inhibitors, waist circumference
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Hypogonadism, Male, Obesity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.